Silo Pharma, Inc. ( SILO) - Key Metrics
SILO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.76 | -$0.71 | -$0.71 |
| 2026Q1 | $0.02 | -$1.80 | -$0.90 | -$0.90 |
| 2025Q4 | $0.02 | -$0.99 | -$0.88 | -$0.88 |
| 2025Q3 | $0.03 | -$1.79 | -$1.54 | -$1.54 |
| 2025Q2 | $0.04 | -$2.88 | -$3.07 | -$3.07 |
SILO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.04 |
| 2026Q1 | 0% | -0.75 |
| 2025Q4 | 0% | -1.28 |
| 2025Q3 | 0% | -1.44 |
| 2025Q2 | 0% | -0.83 |
SILO
Price: $1.18
52 week price:
Earnings Per Share: -3.74 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.7 million